Enhanced production and activation of progelatinase A mediated by membrane-type 1 matrix metalloproteinase in human oral squamous cell carcinomas: Implications for lymph node metastasis

Clinical and Experimental Metastasis

Volumn 18, Issue 2, 2000, Pages 179-188

  Shimada, Taketoshi ^a   Nakamura, Hiroyuki ^b   Yamashita, Kaname ^a   Kawata, Ryo ^c   Murakami, Yasushi ^c   Fujimoto, Noboru ^d   Sato, Hiroshi ^a   Seiki, Motoharu ^e   Okada, Yasunori ^b  

^a KANAZAWA UNIVERSITY   (Japan)

^b KEIO UNIVERSITY   (Japan)

^c KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^d FUJI CHEMICAL INDUSTRIES LTD   (Japan)

^e UNIVERSITY OF TOKYO   (Japan)

Author keywords

Activation of proMMP 2; Lymph node metastasis; Matrix metalloproteinase; Membrane type matrix metalloproteinase; Oral squamous cell carcinoma; Tissue inhibitor of metalloproteinases

Indexed keywords

GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; INTERSTITIAL COLLAGENASE; MATRIX METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ARTICLE; CARCINOMA CELL; CERVICAL LYMPH NODE; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME IMMUNOASSAY; ENZYME INHIBITION; EXTRACELLULAR MATRIX; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPH NODE METASTASIS; MOUTH CARCINOMA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA; ZYMOGRAPHY;

BASE SEQUENCE; CARCINOMA, SQUAMOUS CELL; DNA PRIMERS; ENZYME ACTIVATION; ENZYME PRECURSORS; GELATIN; GELATINASES; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LYMPHATIC METASTASIS; MATRIX METALLOPROTEINASE 15; MATRIX METALLOPROTEINASE 16; MATRIX METALLOPROTEINASES, MEMBRANE-ASSOCIATED; METALLOENDOPEPTIDASES; MOUTH NEOPLASMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 0035109581     PISSN: 02620898     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006749501682     Document Type: Article

References (40)

1. Tumor cell interactions with the extracellular matrix during invasion and metastasis
2. Proteinases and matrix degradation
3. Activation mechanisms of matrix metalloproteinases
4. A matrix metalloproteinase expressed on the surface of invasive tumour cells
5. cDNA sequence and mRNA tissue distribution of a novel human matrix metalloproteinase with a potential transmembrane segment
6. Identification of the second membrane-type matrix metalloproteinase (MT- MMP-2) gene from a human placenta cDNA library. MT-MMPs form a unique membrane-type subclass in the MMP family
7. Molecular cloning of a novel membrane-type matrix metalloproteinase from a human breast carcinoma
8. Identification and characterization of the fifth membrane-type matrix metalloproteinase MT5-MMP
9. Leukolysin/MMP25/MT6-MMP: A novel matrix metalloproteinase specifically expressed in the leukocyte lineage
10. Membrane type 4 matrix metalloproteinase (MT4-MMP, MMP-17) is a glycosylphosphatidylinositol-anchored proteinase
11. Biochemical characterization of the catalytic domain of membrane-type 4 matrix metalloproteinase
12. Identification and characterization of human MT5-MMP, a new membrane-bound activator of progelatinase a overexpressed in brain tumors
13. Interstitial collagenase gene expression in oral squamous cell carcinoma
14. Expression of collagenase-3 (matrix metalloproteinase-13) in squamous cell carcinomas of the head and neck
15. Expression of collagenase-related metalloproteinase genes in human lung or head and neck tumours
16. Increased stromelysin 3 gene expression is associated with increased local invasiveness in head and neck squamous cell carcinomas
17. Membrane-type matrix metalloproteinase (MT-MMP) gene is expressed in stromal cells of human colon, breast, and head and neck carcinomas
18. Expression of matrix metalloproteinases (MMP-1 and 2) and their inhibitors (TIMP- 1, -2, -3) in oral lichen planus, dysplasia, squamous cell carcinoma, lymph node metastasis
19. Expression of matrix metalloproteinase-2 related to lymph node metastasis of oral squamous cell carcinoma. A clinicopathologic study
20. Analysis of expression of matrix metalloproteinases-2 and -9 in hypopharyngeal squamous cell carcinoma by in situ hybridization
21. Expression of matrix metalloproteinase-3 in stage I and II squamous cell carcinoma of the oral cavity
22. Increased expression of membrane type 1-matrix metalloproteinase in head and neck carcinoma
23. Expression of MMPS, MT-MMP, and TIMPs in squamous cell carcinoma of the oral cavity with correlations with tumor invasion and metastasis
24. Gelatinolytic activity of matrix metalloproteinase in tumor tissues correlates with the invasiveness of oral cancer
25. Enhanced production and activation of progelatinase A mediated by membrane-type 1 matrix metalloproteinase in human papillary thyroid carcinomas
26. Enhanced production of matrix metalloproteinases and activation of matrix metalloproteinase 2 (gelatinase A) in human gastric carcinomas
27. Expression and tissue localization of membrane-type 1, 2, and 3 matrix metalloproteinases in human astrocytic tumors
28. Expression and tissue localization of membrane-types 1, 2, and 3 matrix metalloproteinases in human invasive breast carcinomas
29. One-step sandwich enzyme immunoassay for tissue inhibitor of metalloproteinases-2 using monoclonal antibodies
30. Enhanced production and activation of matrix metalloproteinase-7 (matrilysin) in human endometrial carcinomas
31. Expression and tissue localization of matrix metalloproteinase 7 (matrilysin) in human gastric carcinomas. Implications for vessel invasion and metastasis
32. Contribution of matrilysin (MMP-7) to the metastatic pathway of human colorectal cancers
33. Factors influencing prognosis and outcome in differentiated thyroid carcinoma
34. Surgical treatment of papillary thyroid carcinoma: Uni- multivariate analysis of prognostic factors (TNM staging system included)
35. Activation of the precursor of gelatinase A/72 kDa type IV collagenase/MMP-2 in lung carcinomas correlates with the expression of membrane-type matrix metalloproteinase (MT-MMP) and with lymph node metastasis
36. Activity of type IV collagenases in benign and malignant breast disease
37. Expression of membrane-type matrix metalloproteinase in human gastric carcinomas
38. TIMP-2 promotes activation of progelatinase A by membrane-type 1 matrix metalloproteinase immobilized on agarose beads
39. The TIMP2 membrane type 1 metalloproteinase 'receptor' regulates the concentration and efficient activation of progelatinase A. A kinetic study
40. Characterization of a truncated recombinant form of human membrane type 3 matrix metalloproteinase